These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7968757)

  • 1. Who bears the cost of antidepressants in Australia?
    Alchin TM; Tranby HW
    Med J Aust; 1994 Nov; 161(9):547-9. PubMed ID: 7968757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of antidepressant medications.
    Clark DB
    J Clin Psychiatry; 1995 Sep; 56(9):432. PubMed ID: 7665543
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of antidepressants among elderly subjects: trends and contributing factors.
    Mamdani MM; Parikh SV; Austin PC; Upshur RE
    Am J Psychiatry; 2000 Mar; 157(3):360-7. PubMed ID: 10698810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antidepressant treatments on health service utilization and medical costs among patients with depression: a nationwide population-based retrospective cohort study in Taiwan.
    Su KP; Tang CH; Chang HC; Chiu WC; Lu N; Huang KC
    Int Clin Psychopharmacol; 2019 Jul; 34(4):170-178. PubMed ID: 30964763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the consumption of antidepressant drugs in Lithuania in 2002-2004.
    Kadusevicius E; Mikucionyte L; Maciulaitis R; Milvidaite I; Sveikata A
    Medicina (Kaunas); 2006; 42(12):1020-9. PubMed ID: 17211111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Who bears the costs of antidepressants in Australia?
    Gorham PN
    Med J Aust; 1995 Feb; 162(3):162-3; author reply 164. PubMed ID: 7854234
    [No Abstract]   [Full Text] [Related]  

  • 7. Who bears the costs of antidepressants in Australia?
    Haski RR; Grainger D
    Med J Aust; 1995 Feb; 162(3):164. PubMed ID: 7854236
    [No Abstract]   [Full Text] [Related]  

  • 8. Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis.
    Hylan TR; Crown WH; Meneades L; Heiligenstein JH; Melfi CA; Croghan TW; Buesching DP
    J Affect Disord; 1998 Jan; 47(1-3):71-9. PubMed ID: 9476746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective analysis of the health-care costs of bupropion sustained release in comparison with other antidepressants.
    Poret AW; Neslusan C; Ricci JF; Wang S; Khan ZM; Kwong JW
    Value Health; 2001; 4(5):362-9. PubMed ID: 11705126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant use among elderly patients.
    Flint A; Silveira J
    Am J Psychiatry; 2001 Feb; 158(2):328-30. PubMed ID: 11156834
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship of total health care charges to selective serotonin reuptake inhibitor utilization patterns including the length of antidepressant therapy--results from a managed care administrative claims database.
    Eaddy MT; Druss BG; Sarnes MW; Regan TS; Frankum LE
    J Manag Care Pharm; 2005 Mar; 11(2):145-50. PubMed ID: 15766321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who bears the costs of antidepressants in Australia?
    Burrows GD; Norman TR
    Med J Aust; 1995 Feb; 162(3):162; author reply 164. PubMed ID: 7854232
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug Expenditure, Price, and Utilization in the U.S. Medicaid: A Trend Analysis for SSRI and SNRI Antidepressants from 1991 to 2018.
    Alrasheed M; Hincapie AL; Guo JJ
    J Ment Health Policy Econ; 2021 Mar; 24(1):3-11. PubMed ID: 33739932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of treatment: what do new antidepressants offer?
    Lader M
    Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 1():5-9. PubMed ID: 7622812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Newer Antidepressant Medications in U.S. Commercial Health Plans.
    Hodgkin D; Horgan CM; Creedon TB; Merrick EL; Stewart MT
    J Ment Health Policy Econ; 2015 Dec; 18(4):165-73. PubMed ID: 26729008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expenditures.
    Dewa CS; Hoch JS; Goering P
    Clin Ther; 2001 Feb; 23(2):292-306. PubMed ID: 11293562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant agents: from tricyclics to serotonin uptake inhibitors.
    Garattini S; Barbui C; Saraceno B
    Psychol Med; 1998 Sep; 28(5):1169-78. PubMed ID: 9794024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-benefit analysis of newer versus older antidepressants--pharmacoeconomic studies comparing SSRIs/SNRIs with tricyclic antidepressants.
    Laux G
    Pharmacopsychiatry; 2001 Jan; 34(1):1-5. PubMed ID: 11229615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of antidepressant prescribing tendencies in Lithuania in 2003-2004.
    Jakimavicius M; Sveikata A; Vainauskas P; Jankūnas R; Mikucionyte L; Sapoliene A; Smigelskas K
    Medicina (Kaunas); 2007; 43(5):412-8. PubMed ID: 17563418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the use of SSRIs reduce medical care utilization and expenditures?
    Chung S
    J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.